ZA935619B - Cyanoguanidines as k-channel blockers - Google Patents
Cyanoguanidines as k-channel blockersInfo
- Publication number
- ZA935619B ZA935619B ZA935619A ZA935619A ZA935619B ZA 935619 B ZA935619 B ZA 935619B ZA 935619 A ZA935619 A ZA 935619A ZA 935619 A ZA935619 A ZA 935619A ZA 935619 B ZA935619 B ZA 935619B
- Authority
- ZA
- South Africa
- Prior art keywords
- alkyl
- hydrogen
- channel blockers
- formula
- cyanoguanidines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92979592A | 1992-08-13 | 1992-08-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA935619B true ZA935619B (en) | 1995-02-03 |
Family
ID=25458467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA935619A ZA935619B (en) | 1992-08-13 | 1993-08-03 | Cyanoguanidines as k-channel blockers |
Country Status (16)
Country | Link |
---|---|
US (1) | US5567722A (es) |
EP (1) | EP0655057B1 (es) |
JP (1) | JPH08500111A (es) |
CN (1) | CN1039997C (es) |
AT (1) | ATE158279T1 (es) |
AU (2) | AU4530693A (es) |
DE (1) | DE69314041T2 (es) |
DK (1) | DK0655057T3 (es) |
ES (1) | ES2107049T3 (es) |
GR (1) | GR3025640T3 (es) |
IL (1) | IL106641A (es) |
MX (1) | MX9304882A (es) |
MY (1) | MY110826A (es) |
TW (1) | TW223017B (es) |
WO (2) | WO1994004499A1 (es) |
ZA (1) | ZA935619B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9603051A (es) * | 1994-01-28 | 1997-06-28 | Upjohn Co | Cianoguanidinas como bloqueadores del canal-k. |
AUPN193095A0 (en) * | 1995-03-24 | 1995-04-27 | Polychip Pharmaceuticals Pty Ltd | Potassium ion channel blockers |
AR008290A1 (es) * | 1996-08-15 | 1999-12-29 | Smithkline Beecham Corp | Nuevos compuestos que contienen guanidina utiles como antagonistas de los receptores de il-8, composiciones farmaceuticas que los contienenprocedimiento para la preparacion de dichos compuestos y procedimiento para la preparacion de intermediarios. |
EP0939634A4 (en) * | 1996-08-15 | 2001-02-21 | Smithkline Beecham Corp | IL-8 RECEPTOR ANTAGONISTS |
EP1917244A2 (de) | 2005-08-24 | 2008-05-07 | Abbott GmbH & Co. KG | Hetaryl substituierte guanidinverbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren |
CN113683535B (zh) * | 2020-05-18 | 2022-08-30 | 中国药科大学 | 含氰胍结构的化合物及其制备方法与用途 |
CN112042664B (zh) * | 2020-09-18 | 2022-06-10 | 广州古神生物科技有限公司 | 防霉抗菌剂 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1489879A (en) * | 1974-12-20 | 1977-10-26 | Leo Pharm Prod Ltd | N'-cyano-n'-3-pyridylguanidines |
NL8000869A (nl) * | 1979-02-16 | 1980-08-19 | Eisai Co Ltd | Cyanoguanidine-derivaten en werkwijze voor de bereiding daarvan. |
JPH01166119A (ja) * | 1987-12-23 | 1989-06-30 | Hitachi Ltd | データ入力装置の制御方式 |
NZ229828A (en) * | 1988-08-09 | 1992-03-26 | Squibb & Sons Inc | Aryl cyanoguanidine derivatives and pharmaceutical compositions |
PT93033B (pt) * | 1989-02-03 | 1996-03-29 | Lilly Co Eli | Processo para a preparacao de derivados de guanidina |
US5006523A (en) * | 1989-10-26 | 1991-04-09 | E. R. Squibb & Sons, Inc. | Antiarrhythmic agents: aryl cyanoguanidine potassium channel blockers |
-
1993
- 1993-06-11 AU AU45306/93A patent/AU4530693A/en not_active Abandoned
- 1993-06-11 WO PCT/US1993/005458 patent/WO1994004499A1/en active Application Filing
- 1993-07-21 EP EP93917262A patent/EP0655057B1/en not_active Expired - Lifetime
- 1993-07-21 JP JP6506258A patent/JPH08500111A/ja active Pending
- 1993-07-21 DE DE69314041T patent/DE69314041T2/de not_active Expired - Fee Related
- 1993-07-21 DK DK93917262.3T patent/DK0655057T3/da active
- 1993-07-21 WO PCT/US1993/006752 patent/WO1994004500A1/en active IP Right Grant
- 1993-07-21 ES ES93917262T patent/ES2107049T3/es not_active Expired - Lifetime
- 1993-07-21 AT AT93917262T patent/ATE158279T1/de not_active IP Right Cessation
- 1993-07-21 AU AU46831/93A patent/AU4683193A/en not_active Abandoned
- 1993-08-03 ZA ZA935619A patent/ZA935619B/xx unknown
- 1993-08-03 TW TW082106192A patent/TW223017B/zh active
- 1993-08-07 MY MYPI93001565A patent/MY110826A/en unknown
- 1993-08-10 IL IL10664193A patent/IL106641A/en not_active IP Right Cessation
- 1993-08-12 MX MX9304882A patent/MX9304882A/es not_active IP Right Cessation
- 1993-08-13 CN CN93117781A patent/CN1039997C/zh not_active Expired - Fee Related
-
1995
- 1995-02-06 US US08/384,562 patent/US5567722A/en not_active Expired - Fee Related
-
1997
- 1997-12-10 GR GR970403292T patent/GR3025640T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK0655057T3 (da) | 1998-04-14 |
IL106641A0 (en) | 1993-12-08 |
DE69314041T2 (de) | 1998-02-05 |
US5567722A (en) | 1996-10-22 |
MY110826A (en) | 1999-05-31 |
ATE158279T1 (de) | 1997-10-15 |
ES2107049T3 (es) | 1997-11-16 |
WO1994004499A1 (en) | 1994-03-03 |
AU4530693A (en) | 1994-03-15 |
JPH08500111A (ja) | 1996-01-09 |
AU4683193A (en) | 1994-03-15 |
TW223017B (es) | 1994-05-01 |
GR3025640T3 (en) | 1998-03-31 |
IL106641A (en) | 2001-01-11 |
WO1994004500A1 (en) | 1994-03-03 |
DE69314041D1 (de) | 1997-10-23 |
EP0655057A1 (en) | 1995-05-31 |
CN1039997C (zh) | 1998-09-30 |
CN1090575A (zh) | 1994-08-10 |
EP0655057B1 (en) | 1997-09-17 |
MX9304882A (es) | 1994-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL142649A0 (en) | Azole derivatives | |
KR960702460A (ko) | 티아졸리딘디온 및 이것을 함유하는 약제(new thiazolidindiones and drugs containing them) | |
ES2141329T3 (es) | Antifungicos azolicos solubles en agua. | |
DK0654041T3 (da) | Peptidyl-4-amino-2,2-difluor-3-oxo-1,6-hexandisyre-derivater som anto-inflammatoriske midler | |
CA2203237A1 (en) | Aminotetrazole derivatives useful as nitric oxide synthase inhibitors | |
HUT46313A (en) | Process for producing 3/2h/-pyridazine derivatives and pharmaceutical compositions containing them as active components | |
IL106641A0 (en) | Cyanoguanidines as k-channel blockers | |
JPS5750989A (en) | Imidazole compound | |
IT1271411B (it) | Derivati del 2-ammino-1,2,3,4-tetraidro-naftalene attivi sul sistema cardiovascolare | |
GR3029737T3 (en) | Pyrimidine cyanoguanidines as k-channel blockers | |
MY131544A (en) | Fluorinated 4-aminoandrostadienone derivatives and process for their preparation | |
NO20023041L (no) | Fremgangsmåte for fremstilling av pyrazolopyridazinderivater | |
DK0741708T3 (da) | Cyanoguanidiner som K-kanal-blokkere | |
DK1049672T3 (da) | Azetidincarboxamid-derivater til behandling af CNS-lidelser | |
ES8100304A1 (es) | Un procedimiento para preparar derivados de indol policiclicos | |
CA2272098A1 (en) | Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists | |
MY107993A (en) | Orally active antiviral compounds. | |
ZA957025B (en) | Process for the preparation of the (-)-N-methyl-N-(4-(4-phenyl-4-acetylaminopiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl) benzamide and its pharmaceutically acceptable salts | |
SE7713864L (sv) | Nortropinkarbazatderivat och forfarande for framstellning av dem | |
TH14335A (th) | ไซแอโนกัวนิดีนเป็นตัวสกัดกั้นช่องผ่านออกของโพแทสเซียม |